Pyrazinamide
featured

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H592505

CAS#: 98-96-4

Description: Pyrazinamide is a pyrazine that is used therapeutically as an antitubercular agent.


Chemical Structure

img
Pyrazinamide
CAS# 98-96-4

Theoretical Analysis

Hodoodo Cat#: H592505
Name: Pyrazinamide
CAS#: 98-96-4
Chemical Formula: C5H5N3O
Exact Mass: 123.04
Molecular Weight: 123.120
Elemental Analysis: C, 48.78; H, 4.09; N, 34.13; O, 13.00

Price and Availability

Size Price Availability Quantity
10g USD 250
25g USD 450
Bulk inquiry

Synonym: Pyrazinamide

IUPAC/Chemical Name: 2-Pyrazinecarboxamide

InChi Key: IPEHBUMCGVEMRF-UHFFFAOYSA-N

InChi Code: InChI=1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9)

SMILES Code: O=C(C1=NC=CN=C1)N

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 123.12 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Jan F, Wali S, Sadia S, Akbar MT, Akbar HS, Ahmad W, Ahmad M, Khalid A. Drug resistance pattern in Mycobacterium tuberculosis to the first line drugs of pulmonary tuberculosis patients at Hazara Region, Pakistan. Tuberk Toraks. 2018 Mar;66(1):26-31. doi: 10.5578/tt.60781. PubMed PMID: 30020038.

2: Blanc L, Sarathy JP, Alvarez Cabrera N, O'Brien P, Dias-Freedman I, Mina M, Sacchettini J, Savic RM, Gengenbacher M, Podell BK, Prideaux B, Ioerger T, Dick T, Dartois V. Impact of immunopathology on the antituberculous activity of pyrazinamide. J Exp Med. 2018 Jul 17. pii: jem.20180518. doi: 10.1084/jem.20180518. [Epub ahead of print] PubMed PMID: 30018074.

3: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501347/ PubMed PMID: 30000406.

4: Arttawejkul P, Kongpolprom N. A case of pulmonary infection caused by Mycobacterium asiaticum: Difficulties on diagnostic and therapeutic approaches. Respir Med Case Rep. 2018 May 17;24:150-152. doi: 10.1016/j.rmcr.2018.05.014. eCollection 2018. PubMed PMID: 29984149; PubMed Central PMCID: PMC6010662.

5: Amarnath Praphakar R, Jeyaraj M, Ahmed M, Suresh Kumar S, Rajan M. Silver nanoparticle functionalized CS-g-(CA-MA-PZA) carrier for sustainable anti-tuberculosis drug delivery. Int J Biol Macromol. 2018 Jul 6. pii: S0141-8130(18)31765-3. doi: 10.1016/j.ijbiomac.2018.07.008. [Epub ahead of print] PubMed PMID: 29981824.

6: Kusakabe T, Endo K, Nakamura I, Suzuki H, Nishimura H, Fukushima S, Yamamoto K. Bacille Calmette-Guérin (BCG) spondylitis with adjacent mycotic aortic aneurysm after intravesical BCG therapy: a case report and literature review. BMC Infect Dis. 2018 Jun 28;18(1):290. doi: 10.1186/s12879-018-3205-7. PubMed PMID: 29954321; PubMed Central PMCID: PMC6025820.

7: Sharma R, Goyal N, Singla M, Sharma VL. Berberis aristata Ameliorates Testicular Toxicity Induced by Combination of First-Line Tuberculosis Drugs (Rifampicin + Isoniazid + Pyrazinamide) in Normal Wistar Rats. J Diet Suppl. 2018 Jun 28:1-14. doi: 10.1080/19390211.2018.1470127. [Epub ahead of print] PubMed PMID: 29953299.

8: Kalpana, Dwivedi H. Interfacial Phenomenon Based Biocompatible Alginate-Chitosan Nanoparticles Containing Isoniazid and Pyrazinamide. Pharm Nanotechnol. 2018 Jun 25. doi: 10.2174/2211738506666180625120038. [Epub ahead of print] PubMed PMID: 29938624.

9: Khan MT, Malik SI, Bhatti AI, Ali S, Khan AS, Zeb MT, Nadeem T, Fazal S. Pyrazinamide-resistant mycobacterium tuberculosis isolates from Khyber Pakhtunkhwa and rpsA mutations. J Biol Regul Homeost Agents. 2018 May-Jun;32(3):705-709. PubMed PMID: 29921403.

10: Horita Y, Alsultan A, Kwara A, Antwi S, Enimil A, Orstin A, Dompreh A, Yang H, Wiesner L, Peloquin CA. Evaluation of the Adequacy of WHO revised Dosages of the First-Line Anti-Tuberculosis Drugs in Children with Tuberculosis using Population Pharmacokinetic Modeling and Simulations. Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00008-18. doi: 10.1128/AAC.00008-18. [Epub ahead of print] PubMed PMID: 29914960.

11: Shetty NS, Shah I. Isoniazid-induced neuropathy in a pre-pubertal child. Paediatr Int Child Health. 2018 Jun 13:1-3. doi: 10.1080/20469047.2018.1482996. [Epub ahead of print] PubMed PMID: 29897291.

12: Mesfin EA, Beyene D, Tesfaye A, Admasu A, Addise D, Amare M, Dagne B, Yaregal Z, Tesfaye E, Tessema B. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PLoS One. 2018 Jun 4;13(6):e0197737. doi: 10.1371/journal.pone.0197737. eCollection 2018. PubMed PMID: 29864118; PubMed Central PMCID: PMC5986145.

13: Bouzouita I, Cabibbe AM, Trovato A, Draoui H, Ghariani A, Midouni B, Essalah L, Mehiri E, Cirillo DM, Slim-Saidi L. Is sequencing better than phenotypic tests for the detection of pyrazinamide resistance? Int J Tuberc Lung Dis. 2018 Jun 1;22(6):661-666. doi: 10.5588/ijtld.17.0715. PubMed PMID: 29862951.

14: Wu S, Wang W, Chen H, Xiong W, Song X, Yu X. Perianal ulcerative skin tuberculosis: A case report. Medicine (Baltimore). 2018 Jun;97(22):e10836. doi: 10.1097/MD.0000000000010836. PubMed PMID: 29851791.

15: Larsen SE, Baldwin SL, Orr MT, Reese VA, Pecor T, Granger B, Dubois Cauwelaert N, Podell BK, Coler RN. Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment. Vaccines (Basel). 2018 May 24;6(2). pii: E30. doi: 10.3390/vaccines6020030. PubMed PMID: 29795025; PubMed Central PMCID: PMC6027321.

16: Lin S, Guan W, LaZhou C, Shi Y. Left lung hypoplasia with a right tuberculous pleural effusion after childbirth: A case report. Medicine (Baltimore). 2018 May;97(21):e10868. doi: 10.1097/MD.0000000000010868. PubMed PMID: 29794790.

17: Monteiro JTC, Lima KVB, Barretto AR, Furlaneto IP, Gonçalves GM, Costa ARFD, Lopes ML, Dalcolmo MP. Clinical aspects in patients with pulmonary infection caused by mycobacteria of the Mycobacterium abscessus complex, in the Brazilian Amazon. J Bras Pneumol. 2018 Apr;44(2):93-98. doi: 10.1590/s1806-37562016000000378. Portuguese, English. PubMed PMID: 29791556; PubMed Central PMCID: PMC6044653.

18: Vaghela JH, Nimbark V, Barvaliya M, Mehta H, Chavada B. Antituberculosis Drug-Induced Fixed Drug Eruption: A Case Report. Drug Saf Case Rep. 2018 May 21;5(1):23. doi: 10.1007/s40800-018-0086-z. PubMed PMID: 29785553; PubMed Central PMCID: PMC5962523.

19: Arora A, Sadath SA. Genital tuberculosis in postmenopausal women with variable clinical presentations: A report of 3 cases. Case Rep Womens Health. 2018 Mar 30;18:e00059. doi: 10.1016/j.crwh.2018.e00059. eCollection 2018 Apr. PubMed PMID: 29785388; PubMed Central PMCID: PMC5960020.

20: Feng J, Yee R, Zhang S, Tian L, Shi W, Zhang WH, Zhang Y. A Rapid Growth-Independent Antibiotic Resistance Detection Test by SYBR Green/Propidium Iodide Viability Assay. Front Med (Lausanne). 2018 May 3;5:127. doi: 10.3389/fmed.2018.00127. eCollection 2018. PubMed PMID: 29774213; PubMed Central PMCID: PMC5943513.